tiprankstipranks
Trending News
More News >
Science Group PLC (GB:SAG)
LSE:SAG
UK Market

Science (SAG) AI Stock Analysis

Compare
6 Followers

Top Page

GB:SAG

Science

(LSE:SAG)

Select Model
Select Model
Select Model
Outperform 73 (OpenAI - 5.2)
,
Outperform 73 (OpenAI - 5.2)
,
Outperform 73 (OpenAI - 5.2)
,
Outperform 73 (OpenAI - 5.2)
Rating:73Outperform
Price Target:
602.00 p
â–²(9.95% Upside)
Action:ReiteratedDate:03/19/26
The score is driven primarily by improved profitability and a stronger, low-leverage balance sheet, complemented by an attractive low P/E valuation. Offsetting factors are inconsistent/negative recent revenue, some cash-flow conversion volatility, and neutral-to-slightly weak technical momentum.
Positive Factors
Improved profitability
Margins and operating profitability have risen materially, with EBIT margin at ~15.1% in 2025 and net margin near 29.8%. Sustained higher margins indicate stronger pricing, cost discipline and potential for durable earnings power if top-line stabilizes, improving long-term return on capital.
Low leverage / stronger balance sheet
Debt-to-equity falling to ~0.14 and a materially larger equity base de-risks the capital structure. Low leverage provides financial flexibility for investment or downturns, lowers interest burden and supports sustained capital returns or opportunistic M&A over the medium term.
Generally solid cash generation
Free cash flow closely tracking net income over multiple years signals earnings quality and cash conversion capacity. Improved FCF in 2024–25 supports reinvestment and shareholder returns and provides a durable source of funding for growth or balance-sheet strengthening.
Negative Factors
Choppy / negative revenue growth
Inconsistent and recently negative revenue undermines confidence that margin gains are structural. Reliance on cost or margin tailwinds rather than steady top-line growth makes long-term earnings sustainability and organic expansion more uncertain over the next several quarters.
Cash-flow conversion volatility
Material swings in operating cash conversion and a near 20% drop in FCF in 2025 indicate working-capital or timing pressure. Volatile cash conversion weakens the reliability of internally generated funding and raises execution risk for sustained investment or distributions.
Historical profitability volatility
Past swings in profitability, including a notable weakness in 2023, suggest earnings may be cyclical or contain one-off elements. This history raises the risk that recent margin expansion and elevated ROE are not fully durable without consistent revenue trends.

Science (SAG) vs. iShares MSCI United Kingdom ETF (EWC)

Science Business Overview & Revenue Model

Company DescriptionScience Group plc, together with its subsidiaries, provides science and technology-based consultancy services in the United Kingdom, North America, Europe, and internationally. The company operates through R&D Consultancy; Regulatory & Compliance; and Frontier Smart Technologies divisions. It offers product and technology development, scientific and regulatory advice, and registration and compliance services to medical, food and beverage, consumer, industrial, chemical, and energy sectors. The company also provides property services. In addition, it manufactures and sells chips, and modules, which are incorporated into digital radios. The company was formerly known as Sagentia Group plc and changed its name to Science Group plc in July 2015. Science Group plc was incorporated in 2008 and is headquartered in Cambridge, the United Kingdom.

Science Financial Statement Overview

Summary
Strong profitability improvement and a de-risking balance sheet support a solid financial profile (income statement 78; balance sheet 82). Offsets are choppy/negative recent revenue and uneven cash-flow conversion versus net income (cash flow 67), which adds uncertainty to the durability of earnings strength.
Income Statement
78
Positive
Profitability has strengthened meaningfully, with net margin improving from ~4.9% (2023) to ~10.9% (2024) and ~29.8% (2025), alongside higher operating profitability (EBIT margin rising to ~15.1% in 2025). Gross margin has remained fairly steady (~40–44%) across the period, indicating solid pricing and delivery discipline. The key weakness is growth: revenue has been choppy and recently negative (down ~2.2% in 2025 and slightly down in 2024), which tempers confidence that the step-up in earnings is purely structural rather than partly one-off.
Balance Sheet
82
Very Positive
Leverage looks conservative and has improved over time, with debt-to-equity declining from ~0.45 (2020) to ~0.14 (2025), supported by a growing equity base (equity up materially since 2020). Returns have also strengthened, with return on equity rising to ~32.2% in 2025 versus mid-teens in several prior years, signaling improved capital efficiency. The main watch item is that profitability has been volatile historically (notably weaker in 2023), which can make balance-sheet strength more reliant on sustaining the recent earnings profile.
Cash Flow
67
Positive
Cash generation is generally solid, with free cash flow tracking net income closely in most years (near 1.0x in 2022–2025), suggesting earnings quality is reasonably supported by cash. Operating and free cash flow levels improved sharply in 2024–2025 versus 2023. However, cash flow has been uneven: free cash flow fell ~19.6% in 2025 after growth in 2024, and operating cash flow remains less than net income (about ~0.57x in 2025), implying working-capital or timing effects that can create volatility.
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue111.66M110.67M113.34M86.30M81.22M
Gross Profit46.04M45.18M46.25M38.35M35.36M
EBITDA22.35M21.13M15.15M16.64M16.00M
Net Income33.27M12.02M5.52M10.55M9.56M
Balance Sheet
Total Assets163.42M141.09M132.45M127.28M115.94M
Cash, Cash Equivalents and Short-Term Investments75.01M41.45M32.83M46.51M37.19M
Total Debt14.22M15.49M16.90M16.02M16.88M
Total Liabilities60.11M57.09M54.46M49.08M49.64M
Stockholders Equity103.32M84.00M77.99M78.20M66.29M
Cash Flow
Free Cash Flow24.55M18.48M7.83M15.18M9.15M
Operating Cash Flow24.59M18.48M7.91M15.27M14.01M
Investing Cash Flow25.28M723.00K-12.78M-34.00K-19.08M
Financing Cash Flow-15.98M-10.72M-8.49M-6.46M13.08M

Science Technical Analysis

Technical Analysis Sentiment
Negative
Last Price547.50
Price Trends
50DMA
544.30
Negative
100DMA
544.87
Negative
200DMA
546.68
Negative
Market Momentum
MACD
-2.76
Positive
RSI
31.97
Neutral
STOCH
41.11
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:SAG, the sentiment is Negative. The current price of 547.5 is above the 20-day moving average (MA) of 538.00, above the 50-day MA of 544.30, and above the 200-day MA of 546.68, indicating a bearish trend. The MACD of -2.76 indicates Positive momentum. The RSI at 31.97 is Neutral, neither overbought nor oversold. The STOCH value of 41.11 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:SAG.

Science Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
£296.41M7.2814.71%2.13%32.67%-1.61%
73
Outperform
£219.23M7.2932.18%1.46%2.90%419.40%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
57
Neutral
£177.13M34.236.09%1.83%23.37%4.75%
56
Neutral
£101.58M7.606.42%8.80%6.04%-24.55%
52
Neutral
£24.97M-20.021.54%―-4.67%590.48%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:SAG
Science
530.00
112.31
26.89%
GB:GTLY
Gateley (Holdings)
74.00
-52.48
-41.49%
GB:MANO
Manolete Partners Plc
57.00
-28.00
-32.94%
GB:ELIX
Elixirr International Plc
610.00
-81.60
-11.80%
GB:FNTL
Fintel PLC
170.00
-50.79
-23.00%

Science Corporate Events

Stock BuybackRegulatory Filings and Compliance
Science Group Chair Increases Relative Stake After Share Buy-Back
Positive
Mar 20, 2026

Science Group PLC has disclosed that its Executive Chair, Martyn Ratcliffe, holds 8,042,080 ordinary shares in the company, including 80,000 shares held in his self-invested personal pension. Following the company’s ongoing share buy-back programme, the total number of ordinary shares in issue, excluding treasury shares, stands at 41,364,312, giving Ratcliffe a 19.4% stake and underscoring his significant alignment with shareholders and influence over corporate governance.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £618.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock BuybackRegulatory Filings and Compliance
Science Group Buys Back 3.05% of Share Capital for Treasury
Positive
Mar 20, 2026

Science Group plc has executed a share buyback, acquiring 1,300,000 of its 1 pence ordinary shares on 19 March 2026 at an average price of 540 pence per share through broker Panmure Liberum Limited. The purchased shares, representing 3.05% of prior voting rights, will be held in treasury, reflecting capital management actions that may signal confidence in the company’s valuation.

Following this transaction, Science Group now has 41,364,312 ordinary shares in issue excluding treasury, while holding 4,821,562 shares in treasury. The updated share count provides the new denominator for investors’ disclosure calculations under FCA transparency rules, with potential implications for major shareholder reporting and the liquidity profile of the stock.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £618.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock BuybackRegulatory Filings and Compliance
Science Group buys back shares, updates capital structure
Positive
Mar 18, 2026

Science Group plc has repurchased 15,000 of its 1 pence ordinary shares at an average price of 544.33 pence per share, with the transaction executed through Panmure Liberum Limited. The shares, representing 0.04% of prior voting rights, will be held in treasury, indicating continued deployment of capital toward buybacks.

Following this transaction, the company now has 42,664,312 ordinary shares in issue excluding treasury holdings, while 3,521,562 shares are retained in treasury. The updated share count provides the new reference point for investors assessing disclosure thresholds under the FCA’s transparency rules and may marginally enhance earnings per share over time.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £621.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Business Operations and StrategyStock BuybackDividendsFinancial Disclosures
Science Group Delivers Record Profits, Boosts Dividend on Strong 2025 Cash Flows
Positive
Mar 17, 2026

Science Group plc reported record adjusted operating profit of £23.1 million and record adjusted basic earnings per share of 40.2 pence for 2025, as revenue held broadly flat at £111.7 million but operating margin improved to 20.7%. Statutory operating profit more than doubled to £40.9 million, driven by a £24.1 million gain from corporate investment, lifting profit before tax to £41.5 million and statutory basic EPS to 75.1 pence.

The group’s strong cash generation, with £31.8 million from operations and year-end cash of £72.6 million, allowed it to boost net funds to £61.2 million while returning £14.3 million to shareholders through a larger buy-back and maintaining dividends. Reflecting this financial strength and a ROCE of 54.7%, the board proposed a 25% dividend increase and signalled continued buy-backs, while the Sagentia services division improved margins despite slightly lower revenue as it exited low-margin defence work and focused on higher value activities, including selective use of AI tools.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £621.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Business Operations and StrategyStock BuybackRegulatory Filings and Compliance
Science Group Tightens Free Float With Targeted Share Buyback
Positive
Mar 17, 2026

Science Group plc has repurchased 17,500 of its 1 pence ordinary shares at an average price of 535 pence, with all trades executed through Panmure Liberum Limited and the entire block representing about 0.04% of prior voting rights. The shares will be held in treasury, leaving 42,679,312 ordinary shares in issue excluding treasury stock, a new denominator for shareholders assessing disclosure thresholds under the FCA transparency rules.

Following this buyback, Science Group now holds 3,506,562 shares in treasury, signaling continued use of share repurchases as part of its capital allocation strategy. The transaction underscores the company’s active management of its equity base, with potential implications for earnings per share and ownership disclosures for investors monitoring their reportable stakes.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £621.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock BuybackRegulatory Filings and Compliance
Science Group Buys Back Shares, Updates Capital Structure
Positive
Mar 17, 2026

Science Group plc has executed a small share buyback, purchasing 17,500 ordinary shares at 535 pence each through Panmure Liberum Limited, representing 0.04% of its prior voting rights. The acquired shares will be held in treasury, bringing total shares in issue excluding treasury to 42,679,312 and treasury holdings to 3,506,562.

The updated share count provides a new denominator for investors assessing disclosure thresholds under the FCA’s transparency rules. While modest in scale, the buyback signals continued active capital management and may incrementally enhance earnings per share and voting power for remaining shareholders.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £621.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock BuybackRegulatory Filings and Compliance
Science Group Buys Back Shares, Updates Voting Capital and Treasury Holdings
Neutral
Mar 16, 2026

Science Group plc has repurchased 17,500 of its 1 pence ordinary shares at an average price of 532 pence per share, with all trades executed through Panmure Liberum Limited. The buyback represents around 0.04% of existing voting rights, and the repurchased shares will be held in treasury, leaving 42,696,812 ordinary shares in issue excluding treasury, a figure shareholders will use for regulatory disclosure calculations.

The company now holds 3,489,062 shares in treasury following this transaction, slightly increasing its treasury stock position. This adjustment marginally tightens the free float while providing Science Group with continued flexibility over its capital structure, and clarifies the updated denominator for investors assessing their notifiable interests under UK transparency rules.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £621.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Business Operations and StrategyStock BuybackRegulatory Filings and Compliance
Science Group Expands Treasury Position With New Share Buyback
Positive
Mar 13, 2026

Science Group plc has continued its share buyback activity, purchasing 7,500 ordinary shares on 12 March 2026 at an average price of 532 pence per share through Panmure Liberum Limited. The transaction represents about 0.02% of prior voting rights and the repurchased shares will be held in treasury, adjusting the capital structure without immediate dilution to existing shareholders.

Following this buyback, Science Group now has 42,714,312 ordinary shares in issue excluding 3,471,562 treasury shares, a figure that shareholders should use when calculating disclosure thresholds under FCA transparency rules. The move underscores ongoing capital management efforts, which may support earnings per share and signal confidence in the company’s valuation, while modestly altering the free float and voting base.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £621.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Business Operations and StrategyFinancial Disclosures
Science Group Sets Date for 2025 Preliminary Results
Neutral
Mar 11, 2026

Science Group plc has announced it will release its preliminary results for the financial year ended 31 December 2025 on 17 March 2026. The scheduled disclosure of annual performance will give investors and other stakeholders greater visibility into the Group’s recent trading, financial position, and potential strategic direction for the coming year.

The timing of the announcement positions the company to update the market ahead of the new financial cycle and may influence investor sentiment toward its shares on AIM. Stakeholders will look to these results for insights into operational momentum, capital allocation, and how the Group is navigating its competitive landscape.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £621.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Business Operations and StrategyStock BuybackRegulatory Filings and Compliance
Science Group Tightens Share Capital With Latest Buyback
Positive
Mar 11, 2026

Science Group plc has repurchased 10,000 of its 1 pence ordinary shares at an average price of 534 pence per share, with all trades executed through Panmure Liberum Limited and the entire lot to be held in treasury. The buyback represents about 0.02% of prior voting rights and leaves 42,721,812 shares in issue excluding treasury, clarifying the new denominator for investors’ disclosure calculations under UK transparency rules and underscoring the company’s ongoing capital management strategy.

Following this transaction, Science Group now holds 3,464,062 shares in treasury, highlighting its continued use of share repurchases as a tool to manage its balance sheet and potentially enhance shareholder value. The update provides the market with precise share capital figures that may influence institutional reporting obligations and offers further visibility into the company’s approach to capital returns and share liquidity.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £621.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock BuybackRegulatory Filings and Compliance
Science Group Buys Back Shares, Updates Capital Structure
Positive
Mar 10, 2026

Science Group plc has repurchased 17,500 of its 1 pence ordinary shares at an average price of 535.5 pence each, with all trades executed through Panmure Liberum Limited. The transaction, representing about 0.04% of prior voting rights, will see the shares held in treasury, leaving 42,731,812 ordinary shares in issue excluding treasury and 3,454,062 shares held in treasury, a figure shareholders can use for regulatory disclosure calculations.

The move forms part of the company’s ongoing share buyback activity, which can signal management’s confidence in the business and may enhance earnings per share over time. The updated share capital structure also provides greater clarity for investors and regulators monitoring significant holdings under the FCA’s Disclosure Guidance and Transparency Rules.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £621.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock BuybackRegulatory Filings and Compliance
Science Group Tightens Share Count with Treasury Buyback
Neutral
Mar 10, 2026

Science Group plc has repurchased 17,500 of its 1 pence ordinary shares at an average price of 535.5 pence per share, with all trades executed through Panmure Liberum Limited. The transaction represents approximately 0.04% of the company’s prior voting rights and the repurchased shares will be held in treasury, modestly increasing treasury holdings and adjusting the total voting share count used for regulatory disclosure thresholds.

Following this buyback, Science Group now has 42,731,812 ordinary shares in issue excluding 3,454,062 shares held in treasury. The updated share capital structure provides investors with a new denominator for calculating notifiable interests under the FCA’s Disclosure Guidance and Transparency Rules, reflecting the company’s ongoing capital management activities.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £621.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock BuybackRegulatory Filings and Compliance
Science Group Tightens Share Count with Targeted Buyback
Neutral
Mar 4, 2026

Science Group plc has executed a further share buyback, purchasing 17,500 ordinary shares at an average price of 537.5 pence per share through Panmure Liberum. The transaction represents 0.04% of the company’s voting rights and reflects continued use of treasury shares as a capital management tool.

Following this repurchase, Science Group now has 42,749,312 ordinary shares in issue excluding 3,436,562 shares held in treasury. The updated share count provides the new reference denominator for investors’ regulatory disclosure calculations under the FCA’s transparency rules, slightly concentrating existing shareholders’ relative holdings.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £621.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Business Operations and StrategyStock Buyback
Science Group Continues Share Buyback, Boosts Treasury Stock
Positive
Mar 3, 2026

Science Group plc has continued its capital management strategy by repurchasing 17,500 of its 1 pence ordinary shares at an average price of 539 pence, with all shares bought at the same price through broker Panmure Liberum. The transaction represents 0.04% of prior voting rights and the repurchased shares will be held in treasury, leaving 42,766,812 ordinary shares in issue excluding treasury stock, a figure shareholders can use for regulatory disclosure calculations.

By modestly reducing the free float and increasing treasury holdings to 3,419,062 shares, the company maintains flexibility for future capital allocation decisions such as potential reissuance or further buybacks. The move signals ongoing active management of its share capital, which can influence earnings per share metrics and provide clarity for investors monitoring ownership thresholds under FCA transparency rules.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £621.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Regulatory Filings and Compliance
Science Group Updates Total Voting Rights and Share Capital
Neutral
Mar 2, 2026

Science Group plc has confirmed that its total issued share capital, excluding treasury shares, stands at 42,784,312 ordinary shares of 1 penny each, while the company holds an additional 3,401,562 shares in treasury. This updated share count provides the official denominator that investors must use when assessing whether their holdings trigger disclosure obligations under the FCA’s Disclosure and Transparency Rules, ensuring accurate reporting of significant shareholdings and changes in ownership.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £621.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Business Operations and StrategyStock BuybackRegulatory Filings and Compliance
Science Group Buys Back Shares, Adjusts Voting Capital Base
Positive
Feb 24, 2026

Science Group plc has repurchased 17,500 of its own ordinary shares at an average price of 544.5 pence per share, with all shares bought at the same price in a single transaction executed via Panmure Liberum Limited on the AIM market. The buyback represents 0.04% of the company’s prior voting rights, and the repurchased shares will be held in treasury, leaving 42,784,312 ordinary shares in issue excluding treasury, a figure shareholders can use for regulatory disclosure calculations under FCA transparency rules.

Following this transaction, Science Group now holds 3,401,562 shares in treasury, subtly increasing the relative ownership of existing shareholders by reducing the free float. The move signals continued use of share repurchases as a capital allocation tool, potentially reflecting management’s confidence in the company’s valuation and providing incremental support to the share price while refining its capital structure.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £621.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock BuybackRegulatory Filings and Compliance
Science Group Buys Back Shares, Updates Treasury and Share Count
Neutral
Feb 23, 2026

Science Group plc has repurchased 17,500 of its 1 pence ordinary shares at an average price of 547 pence per share, with all trades executed through Panmure Liberum Limited on 20 February 2026. The transaction represents 0.04% of prior voting rights, and the shares will be held in treasury, indicating an ongoing capital management strategy that can influence earnings per share metrics and shareholder ownership dynamics.

Following this buyback, the company now has 42,801,812 ordinary shares in issue excluding treasury, while holding 3,384,062 shares in treasury, a structure relevant for investors calculating their notification thresholds under regulatory disclosure rules. The clarified share count and treasury position provide the market with updated data on Science Group’s equity structure, supporting transparency for stakeholders tracking their percentage holdings and compliance obligations.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £621.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Business Operations and StrategyStock BuybackRegulatory Filings and Compliance
Science Group Tightens Share Structure With Targeted Buyback
Positive
Feb 20, 2026

Science Group plc has repurchased 17,500 of its 1 pence ordinary shares at an average price of 547 pence, with all shares bought at the same price through Panmure Liberum Limited. The transaction represents around 0.04% of prior voting rights, and the shares will be held in treasury, leaving 42,819,312 ordinary shares in issue excluding treasury stock and 3,366,562 shares held in treasury, a figure shareholders can use to assess disclosure thresholds under FCA rules.

The buyback slightly reduces the free float while increasing treasury holdings, signaling continued use of capital management tools to influence share structure and potentially enhance shareholder value. By clarifying the updated share count for regulatory calculations, the company also supports transparency for investors monitoring their notifiable interests and compliance with disclosure requirements.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £621.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock BuybackRegulatory Filings and Compliance
Science Group Continues Share Buyback, Updates Voting Share Count
Positive
Feb 18, 2026

Science Group plc has continued its share buyback activity, purchasing 17,500 ordinary shares at an average price of 545 pence per share, with all trades executed through Panmure Liberum Limited. The transaction represents 0.04% of the company’s voting rights, and the acquired shares will be held in treasury, reinforcing capital management efforts.

Following this latest repurchase, Science Group now has 42,836,812 ordinary shares in issue excluding treasury, while holding 3,349,062 shares in treasury that no longer carry voting rights. The updated share count provides the new reference denominator for investors’ disclosure calculations under UK market transparency rules, with potential implications for reporting thresholds and shareholder notifications.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £621.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Business Operations and StrategyStock BuybackRegulatory Filings and Compliance
Science Group Buys Back Shares, Updates Voting Rights Base
Positive
Feb 16, 2026

Science Group plc has repurchased 4,500 of its 1 pence ordinary shares at an average price of 542.5 pence per share through broker Panmure Liberum, with all shares to be held in treasury. The transaction, representing around 0.01% of prior voting rights, brings the total ordinary shares in issue excluding treasury to 42,854,312, a figure shareholders can now use for regulatory disclosure threshold calculations under FCA rules.

By modestly reducing the free float and increasing treasury holdings to 3,331,562 shares, the company continues its capital management strategy, which can support metrics such as earnings per share and provide flexibility for future corporate actions. The updated share count and clarity on voting rights offer greater transparency for investors monitoring their notifiable interest levels and potential changes in ownership disclosures.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £621.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock BuybackRegulatory Filings and Compliance
Science Group Buys Back Further Shares, Updates Share Capital
Positive
Feb 13, 2026

Science Group plc has continued its share buyback activity, repurchasing 17,500 ordinary shares of 1 pence each on 12 February 2026 at an average price of 541.5 pence per share through Panmure Liberum Limited. The repurchased shares, representing 0.04% of existing voting rights, will be held in treasury, taking treasury holdings to 3,327,062 shares and leaving 42,858,812 ordinary shares in issue excluding treasury.

The updated share capital figure provides investors with a new denominator for calculating disclosure thresholds under the FCA’s transparency rules. The transaction marginally reduces the free float, which can support earnings per share over time and signals continued capital management by the company, though the immediate impact on overall ownership structure is relatively small.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £621.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock BuybackRegulatory Filings and Compliance
Science Group Updates Share Capital After Treasury Share Buyback
Neutral
Feb 12, 2026

Science Group plc has executed a share buyback transaction, repurchasing 15,000 ordinary shares of 1 pence each at an average price of 541.5 pence per share through Panmure Liberum Limited, with all trades executed on the AIMX venue. The shares, representing 0.03% of prior voting rights, will be held in treasury, leaving 42,876,312 ordinary shares in issue (excluding 3,309,562 treasury shares), a figure shareholders may now use to assess notification thresholds under FCA transparency rules.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £621.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock BuybackRegulatory Filings and Compliance
Science Group Executes Modest Share Buyback, Updates Share Capital
Neutral
Feb 11, 2026

Science Group plc has executed a small share buyback, repurchasing 17,500 ordinary shares at an average price of 545 pence per share through Panmure Liberum, with all acquired shares to be held in treasury. The transaction represents 0.04% of pre-buyback voting rights and leaves 42,891,312 ordinary shares in issue excluding treasury holdings, a figure shareholders will use to assess whether they must notify changes in their ownership under UK disclosure regulations.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £621.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock BuybackRegulatory Filings and Compliance
Science Group Buys Back Shares and Updates Voting Capital
Neutral
Feb 9, 2026

Science Group plc has repurchased 11,980 of its own ordinary shares at an average price of 542.5 pence per share as part of its ongoing buyback activity, with all shares acquired through Panmure Liberum Limited and placed into treasury. Following this transaction, the company has 42,908,812 ordinary shares in issue excluding 3,277,062 treasury shares, a structure shareholders must now use when calculating disclosure thresholds under FCA transparency rules.

The buyback represents approximately 0.03% of the company’s prior voting rights, signalling a modest capital management move rather than a transformational shift in ownership structure. By increasing its treasury share holdings, Science Group retains flexibility for future capital allocation decisions, while the updated share count may marginally affect metrics such as earnings per share and regulatory reporting for investors with significant stakes.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £621.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock BuybackRegulatory Filings and Compliance
Science Group Repurchases Shares, Updates Voting Capital and Treasury Position
Neutral
Feb 6, 2026

Science Group plc has repurchased 10,000 of its 1 pence ordinary shares at an average price of 544 pence per share in a transaction executed on 5 February 2026 through Panmure Liberum Limited, with all shares bought at the same price. The buyback represents approximately 0.02% of the company’s voting rights prior to the transaction, and the shares will be held in treasury, bringing total ordinary shares in issue excluding treasury to 42,920,792, while treasury holdings rise to 3,265,082 shares; this updated share capital figure is now the reference denominator for shareholders assessing whether they must disclose changes in their holdings under FCA transparency rules.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £621.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock BuybackRegulatory Filings and Compliance
Science Group Buys Back Shares, Updates Capital Structure and Voting Base
Neutral
Feb 5, 2026

Science Group plc has repurchased 15,000 of its 1 pence ordinary shares at an average price of 547.5 pence per share, representing around 0.03% of its existing voting rights, with all shares bought through Panmure Liberum Limited. The repurchased shares will be held in treasury, bringing the total number of ordinary shares in issue excluding treasury to 42,930,792, a figure that shareholders must now use as the reference denominator when assessing whether they are required to disclose holdings or changes under FCA transparency rules, highlighting the company’s ongoing active capital management and its implications for investor reporting obligations.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £621.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock BuybackRegulatory Filings and Compliance
Science Group Buys Back Shares, Updates Voting Rights and Treasury Holdings
Neutral
Feb 5, 2026

Science Group plc has undertaken a further share buyback, repurchasing 15,000 ordinary shares of 1 pence each on 4 February 2026 at an average price of 547.5 pence per share through Panmure Liberum Limited. The transaction, representing approximately 0.03% of existing voting rights, will see the shares held in treasury, bringing the total number of ordinary shares in issue (excluding treasury shares) to 42,930,792, with 3,255,082 shares now held in treasury; shareholders are advised to use the new share count as the reference figure for regulatory disclosure thresholds under the FCA’s transparency rules.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £621.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock BuybackRegulatory Filings and Compliance
Science Group Buys Back Shares, Updates Treasury and Share Count
Positive
Feb 4, 2026

Science Group plc has executed a small share buyback, repurchasing 17,500 ordinary shares of 1 pence each on 3 February 2026 at an average price of 548.5 pence per share through Panmure Liberum Limited, with all shares to be held in treasury. The transaction represents approximately 0.04% of the company’s prior voting rights and leaves 42,945,792 ordinary shares in issue excluding treasury holdings, with 3,240,082 shares now held in treasury; this updated share count forms the new reference figure for investors’ disclosure and transparency calculations under FCA rules, modestly enhancing capital management flexibility and potentially indicating continued board confidence in the equity.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £621.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock BuybackRegulatory Filings and Compliance
Science Group Buys Back Shares, Adjusts Voting Capital Base
Neutral
Jan 29, 2026

Science Group plc has repurchased 14,500 of its 1 pence ordinary shares at an average price of 550 pence per share, representing 0.03% of the company’s voting rights prior to the transaction, with all purchases executed via Panmure Liberum Limited and the shares to be held in treasury. Following this buyback, the company now has 42,963,292 ordinary shares in issue excluding 3,222,582 treasury shares, a figure that will serve as the reference denominator for shareholders’ disclosure calculations under FCA transparency rules, reflecting ongoing active management of the company’s capital structure.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £621.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock BuybackRegulatory Filings and Compliance
Science Group Buys Back Shares, Updates Share Capital and Treasury Holdings
Neutral
Jan 28, 2026

Science Group plc has executed a small share buyback, purchasing 17,500 of its 1 pence ordinary shares on 27 January 2026 at an average price of 551.96 pence per share through broker Panmure Liberum Limited. The repurchased shares, representing approximately 0.04% of existing voting rights, will be held in treasury, bringing the total number of ordinary shares in issue excluding treasury shares to 42,977,792, with 3,208,082 shares now held in treasury; this updated share capital figure provides the new denominator for investors’ disclosure calculations under the FCA’s transparency rules.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £621.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock BuybackRegulatory Filings and Compliance
Science Group Tightens Free Float with Targeted Share Buyback
Neutral
Jan 27, 2026

Science Group plc has repurchased 5,000 of its own 1 pence ordinary shares at an average price of 550 pence per share, with all trades executed via Panmure Liberum Limited and the shares to be held in treasury. The transaction represents approximately 0.01% of the company’s voting rights prior to the buyback and leaves 42,995,292 ordinary shares in issue excluding treasury holdings, with 3,190,582 shares now held in treasury; shareholders are advised to use the updated share count as the reference figure for disclosure obligations under the FCA’s transparency rules, reflecting an incremental tightening of the company’s free float and potential capital management intentions.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £621.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock BuybackRegulatory Filings and Compliance
Science Group Updates Share Count After Small Treasury Buyback
Neutral
Jan 23, 2026

Science Group plc has repurchased 1,650 of its 1 pence ordinary shares at an average price of 555 pence per share on 22 January 2026 via Panmure Liberum Limited, with all shares bought at the same price. The buyback represents 0.004% of the existing voting rights, and the acquired shares will be held in treasury, bringing the total number of ordinary shares in issue excluding treasury shares to 43,000,292, while treasury holdings rise to 3,185,582 shares; this updated share count will serve as the reference denominator for shareholders assessing notification thresholds under the FCA’s Disclosure Guidance and Transparency Rules.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £621.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock BuybackRegulatory Filings and Compliance
Science Group Buys Back Shares, Updates Voting Rights and Share Capital
Neutral
Jan 22, 2026

Science Group plc has repurchased 17,500 of its 1 pence ordinary shares at an average price of 555 pence per share, representing approximately 0.04% of the company’s voting rights prior to the transaction. The shares, bought through Panmure Liberum Limited, will be held in treasury, bringing the total number of ordinary shares in issue excluding treasury shares to 43,001,942, with 3,183,932 shares now held in treasury; this updated share count provides the new reference figure for shareholders assessing notification thresholds under the FCA’s Disclosure Guidance and Transparency Rules.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £621.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock BuybackRegulatory Filings and Compliance
Science Group Buys Back 17,500 Shares for Treasury
Positive
Jan 21, 2026

Science Group plc has executed a small share buyback, purchasing 17,500 of its 1 pence ordinary shares on 20 January 2026 at an average price of 553 pence per share via Panmure Liberum Limited, with all repurchased shares to be held in treasury. The transaction, representing about 0.04% of the company’s prior voting rights, increases Science Group’s treasury holding to 3,166,432 shares and leaves 43,019,442 ordinary shares in issue (excluding treasury), a figure shareholders can now use as the reference denominator for calculating and reporting notifiable holdings under FCA Disclosure Guidance and Transparency Rules, underscoring the company’s active capital management and potential implications for investor reporting obligations.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £621.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock BuybackRegulatory Filings and Compliance
Science Group Buys Back Shares, Updates Voting Capital
Neutral
Jan 20, 2026

Science Group plc has executed another share buyback, purchasing 17,500 of its 1 pence ordinary shares at an average price of 553 pence per share on 19 January 2026 through Panmure Liberum Limited. The repurchased stock, representing about 0.04% of prior voting rights, will be held in treasury, bringing total shares in issue excluding treasury to 43,036,942 and treasury shares to 3,148,932; this updated capital structure figure now serves as the reference point for shareholders assessing disclosure thresholds under UK transparency rules.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £621.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock BuybackRegulatory Filings and Compliance
Science Group Updates Share Capital After Treasury Share Buyback
Neutral
Jan 14, 2026

Science Group plc has repurchased 17,700 of its 1 pence ordinary shares on 13 January 2026 at an average price of 560.47 pence per share, with the transactions executed through Panmure Liberum Limited. The buyback, representing 0.04% of prior voting rights, will be held in treasury, bringing the total number of ordinary shares in issue excluding treasury to 43,054,442 and treasury holdings to 3,131,432 shares; this updated share capital figure now serves as the reference denominator for shareholders determining disclosure obligations under the FCA’s transparency rules.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £621.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Business Operations and StrategyStock BuybackFinancial Disclosures
Science Group Flags Record 2025 Profit and Extends 2026 Share Buy-Back Plan
Positive
Jan 13, 2026

Science Group expects to report a record adjusted operating profit for 2025, ahead of board expectations, driven by a second-half recovery in its Services division, especially in the Medical sector, and boosted by investment gains from first-half corporate activity, which will substantially lift reported profit before tax and earnings per share. Supported by consistently high cash conversion and net funds rising to £61.2 million after returning £14.3 million to shareholders in 2025, the company plans to continue its share buy-back programme in 2026 at a similar scale, arguing that its strong long-term share price outperformance versus UK small- and mid-cap indices highlights a disconnect between its market valuation and operating performance and underpins its capital allocation strategy.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £621.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock Buyback
Science Group Buys Back Shares, Updates Voting Capital and Treasury Position
Neutral
Jan 13, 2026

Science Group plc has repurchased 17,500 of its 1 pence ordinary shares at an average price of 550 pence per share, representing around 0.04% of the company’s voting rights prior to the transaction. The shares, acquired via Panmure Liberum Limited, will be held in treasury, leaving 43,072,142 ordinary shares in issue excluding treasury holdings and 3,113,732 shares held in treasury overall, a figure that shareholders can use in calculating disclosure thresholds under the FCA’s transparency rules.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £621.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock BuybackRegulatory Filings and Compliance
Science Group Continues Share Buyback, Updates Share Capital and Treasury Holdings
Positive
Jan 9, 2026

Science Group plc has continued its share buyback activity, repurchasing 2,000 ordinary shares at an average price of 547.5 pence per share on 8 January 2026 through Panmure Liberum Limited, with all acquired shares to be held in treasury. Following this transaction, the company has 43,089,642 ordinary shares in issue excluding 3,096,232 treasury shares, a capital structure detail that will be used by investors for calculating disclosure thresholds under the FCA’s transparency rules and signals ongoing active capital management by the group.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £621.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Business Operations and StrategyStock Buyback
Science Group Repurchases Shares for Treasury in Ongoing Buyback Activity
Positive
Jan 8, 2026

Science Group plc has executed a share buyback transaction, repurchasing 17,500 of its 1 pence ordinary shares on 7 January 2026 at an average price of 549 pence per share via Panmure Liberum Limited, with all shares to be held in treasury. The buyback, representing about 0.04% of the company’s prior voting rights, leaves 43,091,642 ordinary shares in issue excluding treasury stock and 3,094,232 shares held in treasury, a figure that will now serve as the reference denominator for shareholders’ regulatory disclosure calculations, and signals continued capital management activity that can support earnings per share and shareholder value over time.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £621.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock BuybackRegulatory Filings and Compliance
Science Group Buys Back Shares, Adjusts Free-Float and Treasury Holdings
Neutral
Jan 7, 2026

Science Group plc has repurchased 17,500 of its own 1 pence ordinary shares at an average price of 547.5 pence per share in a transaction executed on 6 January 2026 through Panmure Liberum Limited. The buyback represents 0.04% of the company’s prior voting rights, and the shares will be held in treasury, leaving 43,109,142 ordinary shares in issue excluding treasury stock and 3,076,732 shares now held in treasury, a figure shareholders can use to assess disclosure thresholds under UK transparency rules.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £621.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock BuybackRegulatory Filings and Compliance
Science Group Buys Back 17,000 Shares for Treasury, Updates Capital Base
Neutral
Jan 6, 2026

Science Group plc has continued its share buyback activity, purchasing 17,000 ordinary shares of 1 pence each on 5 January 2026 at an average price of 548 pence per share through Panmure Liberum Limited. The shares, representing approximately 0.04% of the company’s prior voting rights, will be held in treasury, bringing the total number of ordinary shares in issue excluding treasury shares to 43,126,642 and treasury holdings to 3,059,232 shares; this updated capital structure figure will serve as the new denominator for investors assessing disclosure thresholds under FCA transparency rules.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £621.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Regulatory Filings and Compliance
Science Group Updates Total Voting Rights and Share Capital
Neutral
Jan 2, 2026

Science Group plc has confirmed that its total issued share capital, excluding treasury shares, comprises 43,143,642 ordinary shares of 1 penny each, while the company also holds 3,042,232 shares in treasury. The updated share capital figure serves as the key denominator for investors when calculating whether their holdings trigger disclosure obligations under the UK Financial Conduct Authority’s Disclosure and Transparency Rules, providing clarity for shareholders and the market on reporting thresholds for changes in ownership stakes.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £621.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 19, 2026